Compare Paychex, Inc. (PAYX) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Paychex, Inc. vs Tempus AI — how do they compare? Paychex, Inc. trades at $104.29 (market cap $36.15B), while Tempus AI trades at $70 (market cap $12.77B). The key difference: Paychex, Inc. is far larger — about 2.8× Tempus AI's market cap, and Paychex, Inc. pays a 4.69% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Paychex, Inc. for 56 Days and Tempus AI for 22 Days on average.
| PAYX | TEM | |
|---|---|---|
Market Cap | $36.15B | $12.77B |
Volume | 2,429,537 | 8,980,490 |
Sector | Industrials | Broad Market / Factor |
52-Week High | $128.59 | $99.28 |
52-Week Low | $85.57 | $41.55 |
Typical Hold Time | 56 Days | 22 Days |
Enterprise Value | $39.84B | $13.40B |
Dividend Yield | 4.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Paychex (PAYX) trades at $104.46, up 3.41% today, but remains in a bearish technical trend with resistance near $103. The company reported strong Q2 2026 earnings, beating estimates with EPS of $1.34, and maintains robust profitability with a net margin of 27.35%. Recent news highlights concerns over labor market cooling and dividend sustainability despite consistent payouts.
Outlook is mixed: solid fundamentals and a $111 consensus price target suggest upside, but bearish technicals and competitive pressures pose risks. The stock offers income via dividends, yet investor sentiment is cautious amid earnings quality questions and macroeconomic headwinds affecting small business employment trends.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Paychex, Inc.
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
